/Investor DB

V-Bio Ventures — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

ATB Therapeuticsatbtherapeutics.comin𝕏Dec 2024✓ verified

ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments.

BiotechHealthtechMedical Devices

Dr. Mark Throsby(Chief Executive Officer)

Co-investorsMRL Ventures FundVIVES PartnersEQT Life SciencesSambrinvestWallonie EntreprendreEQT

Protealisprotealis.cominJan 2024✓ verified

Protealis breeds legume crops such as soybeans and yellow peas and develops proprietary seed coatings with nitrogen-fixing bacteria adapted to the European climate.

AgTechBiotechFoodTechGent, BE

Benjamin Laga(Co-founder & CEO)inJonas Aper(Co-founder & Director of Breeding)in

Co-investorsAgri Investment FundInnovation IndustriesKorysEstari GroupVIBPMV+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.